Deutsche Bank Ag\ Imv Inc. Transaction History

Deutsche Bank Ag\

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$2.92 - $4.41 $455,011 - $687,192	-155,826 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.9 - $4.4 $440,005 - $667,594	151,726 Added 3700.63%	155,826 $480,000
Q3 2020 Nov 12, 2020	BUY	$2.87 - $5.95 $11,767 - $24,395	4,100 New	4,100 $18,000
Q1 2020 May 14, 2020	SELL	$1.4 - $4.92 $583 - $2,051	-417 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.15 - $3.1 $860 - $1,240	400 Added 2352.94%	417 $1,000
Q1 2019 May 15, 2019	SELL	$3.6 - $5.84 $31,320 - $50,808	-8,700 Reduced 99.8%	17 $0
Q4 2018 Feb 14, 2019	SELL	$4.93 - $6.34 $62,098 - $79,858	-12,596 Reduced 59.1%	8,717 $44,000
Q3 2018 Nov 14, 2018	SELL	$4.65 - $5.94 $375,720 - $479,952	-80,800 Reduced 79.13%	21,313 $126,000
Q2 2018 Aug 14, 2018	BUY	$4.42 - $7.13 $451,339 - $728,065	102,113 New	102,113 $518,000

Ticker IMV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,452,200
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.